SymBio Pharmaceuticals (TSE:4582) Total Tax Payable: 円119 Mil (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4582 SymBio Pharmaceuticals Ltd TSE:4582
36 GF Score
Price 円71.00
GF Value 円59.63
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is SymBio Pharmaceuticals Total Tax Payable?

SymBio Pharmaceuticals TSE:4582 36 Total Tax Payable is 円119 Mil as of Dec. 2025. GuruFocus rates TSE:4582 with a GF Score™ of 36/100 and a GF Value™ of 円59.63 (Modestly Overvalued). The stock has 6 warning signs investors should review.

SymBio Pharmaceuticals's Total Tax Payable for the quarter that ended in Dec. 2025 was 円119 Mil.

SymBio Pharmaceuticals's quarterly Total Tax Payable declined from Jun. 2025 (円99 Mil) to Sep. 2025 (円55 Mil) but then increased from Sep. 2025 (円55 Mil) to Dec. 2025 (円119 Mil).

SymBio Pharmaceuticals's annual Total Tax Payable increased from Dec. 2023 (円18 Mil) to Dec. 2024 (円102 Mil) and increased from Dec. 2024 (円102 Mil) to Dec. 2025 (円119 Mil).

SymBio Pharmaceuticals Total Tax Payable Related Terms

SymBio Pharmaceuticals Total Tax Payable Historical Data

* Premium members only.

The historical data trend for SymBio Pharmaceuticals's Total Tax Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SymBio Pharmaceuticals Total Tax Payable Chart

SymBio Pharmaceuticals Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Tax Payable
Get a 7-Day Free Trial Premium Member Only Premium Member Only 899.64 401.07 18.47 102.01 118.55

SymBio Pharmaceuticals Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Total Tax Payable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 62.15 99.46 54.94 118.55 69.04
TSE:4582
36GF Score
SymBio Pharmaceuticals Ltd TSE:4582
Total Tax Payable is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SymBio Pharmaceuticals Total Tax Payable Calculation

Total Tax Payable is the taxes liability owed to federal, state, and local tax authorities. It is the carrying value as of the balance sheet date of obligations incurred and payable for statutory income, sales, use, payroll, excise, real, property and other taxes.

Frequently Asked Questions Learn more about Total Tax Payable →
What does a Total Tax Payable of 円119 Mil mean?
SymBio Pharmaceuticals (TSE:4582) has a Total Tax Payable of 円119 Mil as of Dec. 2025. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on SymBio Pharmaceuticals and its competitors.
Is SymBio Pharmaceuticals' Total Tax Payable too high?
SymBio Pharmaceuticals' current Total Tax Payable is 円119 Mil. Overall, SymBio Pharmaceuticals has a GF Score™ of 36/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does SymBio Pharmaceuticals' Total Tax Payable compare to ZTS?
SymBio Pharmaceuticals' Total Tax Payable of 円119 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Tax Payable for a Drug Manufacturers company?
A good Total Tax Payable depends on the Drug Manufacturers industry context. However, Total Tax Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Tax Payable mean?
A high Total Tax Payable can signal that a stock is expensive relative to its fundamentals. Tax Payable is the taxes liability owed to federal, state, and local tax authorities. View historical data on SymBio Pharmaceuticals and its competitors. SymBio Pharmaceuticals's current Total Tax Payable is 円119 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SymBio Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, SymBio Pharmaceuticals (TSE:4582) is currently considered Modestly Overvalued. The stock's GF Value™ is 円59.63, compared to a current price of 円71.00 — trading 19.1% above its estimated fair value. The current Total Tax Payable is 円119 Mil. SymBio Pharmaceuticals' overall GF Score™ is 36/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Tax Payable calculated?
Total Tax Payable is calculated from a company's financial statements. For SymBio Pharmaceuticals (TSE:4582), the current Total Tax Payable is 円119 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SymBio Pharmaceuticals (TSE:4582) Overvalued in 2026?

Based on GuruFocus' analysis, SymBio Pharmaceuticals stock appears to be overvalued. The current stock price of 円71.00 is trading 19.1% above its estimated GF Value™ of 円59.63. GuruFocus considers SymBio Pharmaceuticals to be Modestly Overvalued.

Key valuation signals for TSE:4582:

  • Total Tax Payable: 円119 Mil
  • GF Value™: 円59.63 vs. price of 円71.00 (19.1% above fair value)
  • GF Score™: 36/100 with 6 warning signs

No single metric tells the full story. See the TSE:4582 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SymBio Pharmaceuticals Business Description

Address 1-28 Toranomon 4-chome, 7th Floor, Toranomon Towers Office, Minato-ku, Tokyo, JPN, 105-0001
SymBio Pharmaceuticals Ltd is a biopharmaceutical company engaged in development of new drugs with a primary focus on the treatment of rare diseases, mainly in the areas of oncology, hematology and multiple viral infections, and conduct integrated business activities that encompass search for new drug candidates, development, manufacturing, and sales.
36GF Score

Get the complete analysis for TSE:4582

Total Tax Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円71.00
Price
円59.63
GF Value